Colon cancer is a disease that lends itself to molecular profiling. Various molecular and clinical factors influence the prognosis and prescribed treatment. The overall treatment plan will depend on the tumors’ location, histological type and specific molecular characteristics (e.g. status of microsatellites, mutation of the RAS, BRAF, PI3K genes, HER2 expression, etc.) as well the location of any metastases and other factors.